ecNumber*2.7.1.32#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Cyberlindnera jadinii#literature*641367#!ecNumber*2.7.1.32#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Rattus norvegicus#literature*641372#!ecNumber*2.7.1.32#specificActivity*-999#specificActivityMaximum*#commentary*exponentially growing cells: 484.04 pmol/mg/min (activity is determined after homogenizing a cell pellet in Tris/HCl buffer. Homogenisate of exponentially growing and confluent cells is centrifugated. Assay mixture containing 40 mM Tris/HCl with unlabelled carrier of 0.25 mM choline, (methyl-3H)choline (37 kBq/sample), 2 mM ATP and 10 mM MgCl2 were added to homogenate protein. After incubation, reaction is stopped by addition of ice-cold mixture of methanol and chloroform and lipid-metabolite extraction is then carried out. Protein content is set for each sample and total radioactivity is determined. Separation of (methyl-3H)-phosphocholine and (methyl-3H)-choline is carried out using ion exchange chromatography)#organism*Homo sapiens#literature*671362#!ecNumber*2.7.1.32#specificActivity*-999#specificActivityMaximum*#commentary*Genes significantly down-regulated by choline kinase: BCL2-interacting killer (apoptosis-inducing), stabilization of the calcium channel, cyclin G2. Inhibition of cell proliferation, T-cell surface protein tactile, cyclin-dependent kinase inhibitor 1A (p21, Cip1), cyclin-dependent kinase inhibitor 1B (p27, Kip1), dual-specificity-(Y)-tyrosine phosphor regulated kinase, Mad signalling (altered response to quimiotherapy), opioid receptor, mu 1 (negative regulat of cell proliferation), retinoblastoma-like 1 (p107) (Rb associated protein), transforming growth factor, beta receptor I, Toll like receptor (antitumoral immunity), immune escape of human cancer, Visinin like 1#organism*Homo sapiens#literature*687121#!ecNumber*2.7.1.32#specificActivity*-999#specificActivityMaximum*#commentary*The specific activity of choline kinase in wild type zinc-depleted cells is 2.7fold greater when compared with the activity from cells grown with 1.5 microM ZnSO4. Choline kinase activity is measured in a reaction mixture that contains 67 mM glycine-NaOH, 5 mM (methyl-14C)choline, 5 mM ATP, 10mM MgSO4 and 1.3 mM dithiothreitol. The radiolabeled product phosphocholine, is separated from the substrate by precipitation of choline as a reineckate salt.#organism*Saccharomyces cerevisiae#literature*687686#!ecNumber*2.7.1.32#specificActivity*-999#specificActivityMaximum*#commentary*increase in mRNA levels results in an increase in protein expression and ChoK enzymatic activity#organism*Homo sapiens#literature*688743#!ecNumber*2.7.1.32#specificActivity*-999#specificActivityMaximum*#commentary*62.2 micromol/min/mg for ethanolamine#organism*Plasmodium falciparum 3D7#literature*702145#!ecNumber*2.7.1.32#specificActivity*0.000139#specificActivityMaximum*#commentary*skeletal muscle, hindlimbs of +/+ CK-alpha mice, supernatant of tissue homogenates are incubated in volume of 0.100 ml of reaction buffer at 37&Acirc;&deg;C for 30 min. The reaction product, phosphocholine, is separated using an AG1-X8 column.To determine the activity of each CK isoform, supernatant fractions are treated with an antisera raised against GST (control), GST-CK-alpha or GST-CK-beta fusion proteins combined with protein A-Sepharose overnight at 4&Acirc;&deg;C, and the supernatant is used.#organism*Mus musculus#literature*687709#!ecNumber*2.7.1.32#specificActivity*0.000484#specificActivityMaximum*#commentary*in 40 mM Tris/HCl with 10 mM MgCl2, 2 mM ATP and 0.25 mM choline, pH 7.4, at 37&Acirc;&deg;C#organism*Homo sapiens#literature*671362#!ecNumber*2.7.1.32#specificActivity*0.0045#specificActivityMaximum*#commentary*pH 9.0#organism*Rattus norvegicus#literature*641352#!ecNumber*2.7.1.32#specificActivity*0.119#specificActivityMaximum*#commentary*#organism*Rattus norvegicus#literature*641360#!ecNumber*2.7.1.32#specificActivity*0.169#specificActivityMaximum*#commentary*#organism*Rattus norvegicus#literature*641348#!ecNumber*2.7.1.32#specificActivity*1.5#specificActivityMaximum*#commentary*#organism*Rattus norvegicus#literature*641345#!ecNumber*2.7.1.32#specificActivity*2.4#specificActivityMaximum*#commentary*isozyme CKB-2, pH 10.0, 37&Acirc;&deg;C#organism*Caenorhabditis elegans#literature*641375#!ecNumber*2.7.1.32#specificActivity*10.67#specificActivityMaximum*#commentary*2 microgram of purified protein is incubated with a reaction mixture of 100 mM MOPS (pH 7.8), 6 mM MgCl2 and 5 mM ATP, with either 2 mM ethanolamine and 200 nanoCi of [3H]ethanolamine or 2 mM choline and 200 nanoCi of (3H)choline at 37&Acirc;&deg;C for 20 min and quenched by boiling at 100&Acirc;&deg;C for 5 min. Substrates and products are separated by high-performance TLC using silica 60 plates with methanol/0.6% NaCl/ammonium hydroxide as solvent. Radiolabelled species are detected by fluorography at -70&Acirc;&deg;C.#organism*Trypanosoma brucei#literature*685011#!ecNumber*2.7.1.32#specificActivity*10.8#specificActivityMaximum*#commentary*recombinant protein#organism*Plasmodium falciparum 3D7#literature*702145#!ecNumber*2.7.1.32#specificActivity*17.9#specificActivityMaximum*#commentary*#organism*Cuscuta reflexa#literature*641362#!ecNumber*2.7.1.32#specificActivity*40.4#specificActivityMaximum*#commentary*30&Acirc;&deg;C, pH 8.0#organism*Rattus norvegicus#literature*641359#!ecNumber*2.7.1.32#specificActivity*40.4#specificActivityMaximum*#commentary*30&Acirc;&deg;C#organism*Rattus norvegicus#literature*641371#!ecNumber*2.7.1.32#specificActivity*43#specificActivityMaximum*#commentary*isozyme CKA-2, pH 10.0, 37&Acirc;&deg;C#organism*Caenorhabditis elegans#literature*641375#!ecNumber*2.7.1.32#specificActivity*143#specificActivityMaximum*#commentary*pH 8.5, 37&Acirc;&deg;C#organism*Rattus norvegicus#literature*641368#!ecNumber*2.7.1.32#specificActivity*143#specificActivityMaximum*#commentary*pH 8.5, 37&Acirc;&deg;C#organism*Rattus norvegicus#literature*641370#